BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2532471)

  • 1. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M; Bélanger A; Tremblay RR
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
    Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin modulates peripheral androgen metabolism.
    Serafini P; Lobo RA
    Fertil Steril; 1986 Jan; 45(1):41-6. PubMed ID: 2935426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL; Horton N; Rittmaster RS
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
    Khoury MY; Baracat EC; Pardini DP; Vieira JG; de Lima GR
    Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in androgen conjugate levels in women and men with alopecia.
    Legro RS; Carmina E; Stanczyk FZ; Gentzschein E; Lobo RA
    Fertil Steril; 1994 Oct; 62(4):744-50. PubMed ID: 7926083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
    Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
    J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of endogenous progesterone on serum levels of 5 alpha-reduced androgens in hirsute women.
    Dewis P; Newman M; Anderson DC
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):383-92. PubMed ID: 6542470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.